Insider Trading & Ownership - GRAY SUSANNAH

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for GRAY SUSANNAH
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-11-24
Purchase
2020-11-25
7:58 pm
MARAVAI LIFESCIENCES HOLDINGS INC.MRVIGRAY SUSANNAH
Director
20,000$27$540,00031,852
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-08-16
Disposition
2024-08-20
7:07 pm
N/A
2031-04-26
Morphic Holding Inc.MORFGRAY SUSANNAH
Director
71,364$00
(Direct)
View
2024-06-04
Option Award
2024-06-05
7:11 pm
N/A
2034-06-03
Morphic Holding Inc.MORFGRAY SUSANNAH
Director
23,168$023,168
(Direct)
View
2024-05-23
Option Award
2024-05-24
5:57 pm
N/A
N/A
MARAVAI LIFESCIENCES HOLDINGS INC.MRVIGRAY SUSANNAH
Director
20,645$10.7880,768
(Direct)
View
2024-05-21
Option Award
2024-05-23
7:10 pm
N/A
2034-05-20
4D Molecular Therapeutics Inc.FDMTGRAY SUSANNAH
Director
22,500$022,500
(Direct)
View
2024-05-08
Option Award
2024-05-10
6:06 pm
N/A
2034-05-07
Theravance Biopharma Inc.TBPHGRAY SUSANNAH
Director
34,113$055,064
(Direct)
View
2023-07-17
Option Award
2023-07-19
4:49 pm
N/A
N/A
MARAVAI LIFESCIENCES HOLDINGS INC.MRVIGRAY SUSANNAH
Director
24,000$060,123
(Direct)
View
2023-06-01
Option Award
2023-06-02
7:05 pm
N/A
2033-05-31
Morphic Holding Inc.MORFGRAY SUSANNAH
Director
12,535$012,535
(Direct)
View
2023-05-23
Option Award
2023-05-25
7:33 pm
N/A
2033-05-22
4D Molecular Therapeutics Inc.FMDTGRAY SUSANNAH
Director
22,500$022,500
(Direct)
View
2023-05-02
Option Award
2023-05-04
6:38 pm
N/A
2033-05-01
Theravance Biopharma Inc.TBPHGRAY SUSANNAH
Director
31,176$042,995
(Direct)
View
2023-02-26
Option Award
2023-02-28
8:17 pm
N/A
2033-02-25
Theravance Biopharma Inc.TBPHGRAY SUSANNAH
Director
44,485$044,485
(Direct)
View
2022-06-08
Option Award
2022-06-10
7:00 pm
N/A
2032-06-07
Morphic Holding Inc.MORFGRAY SUSANNAH
Director
17,550$017,550
(Direct)
View
2022-05-23
Option Award
2022-05-25
7:01 pm
N/A
2032-05-22
4D Molecular Therapeutics Inc.FDMTGRAY SUSANNAH
Director
22,500$022,500
(Direct)
View
2021-04-27
Option Award(A)
2022-04-29
4:14 pm
N/A
2031-04-26
Morphic Holding Inc.MORFGRAY SUSANNAH
Director
18,111$018,111
(Direct)
View
2021-06-16
Option Award(A)
2022-04-29
4:12 pm
N/A
2031-06-16
Morphic Holding Inc.MORFGRAY SUSANNAH
Director
0$00
(Direct)
View
2022-03-29
Disposition
2022-03-29
4:30 pm
N/A
N/A
Apria Inc.APRGRAY SUSANNAH
Director
5,059$37.50
(Direct)
View
2021-11-19
Option Award
2021-11-23
4:16 pm
N/A
N/A
MARAVAI LIFESCIENCES HOLDINGS INC.MRVIGRAY SUSANNAH
Director
4,271$036,123
(Direct)
View
2021-06-16
Option Award
2021-06-17
7:10 pm
N/A
2031-06-16
Morphic Holding Inc.MORFGRAY SUSANNAH
Director
12,000$012,000
(Direct)
View
2021-06-10
Option Award
2021-06-14
7:40 pm
N/A
N/A
Apria Inc.APRGRAY SUSANNAH
Director
5,059$05,059
(Direct)
View
2021-05-17
Option Award
2021-05-19
8:30 pm
N/A
2031-05-16
4D Molecular Therapeutics Inc.FDMTGRAY SUSANNAH
Director
22,500$022,500
(Direct)
View
2021-04-27
Option Award
2021-04-29
7:10 pm
N/A
2031-04-26
Morphic Holding Inc.MORFGRAY SUSANNAH
Director
24,000$024,000
(Direct)
View

Ownership
2021-04-29
7:07 pm
N/A
N/A
Morphic Holding Inc.MORFGRAY SUSANNAH
Director
0$00
(Direct)
View

Ownership
2020-12-10
7:14 pm
N/A
2030-09-16
4D Molecular Therapeutics Inc.FDMTGRAY SUSANNAH
Director
0$045,000
(Direct)
View
2020-11-19
Option Award
2020-11-23
5:27 pm
N/A
N/A
MARAVAI LIFESCIENCES HOLDINGS INC.MRVIGRAY SUSANNAH
Director
11,852$011,852
(Direct)
View
(A) Indicate amendment filing.